[Protective effect of organic Ca antagonists (iproveratril, D 600, prenylamine) against isoproterenol-induced myocardial necrosis].
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D002118:Calcium / Q000037:antagonists & inhibitors; D006321:Heart / Q000187:drug effects; D006331:Heart Diseases / Q000139:chemically induced / Q000188:drug therapy*; D007545:Isoproterenol / Q000037:antagonists & inhibitors*; D009336:Necrosis; D009570:Nitriles / Q000627:therapeutic use*; D011299:Prenylamine / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014700:Verapamil / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D009570:Nitriles; D014665:Vasodilator Agents; D014700:Verapamil; D011299:Prenylamine; D007545:Isoproterenol; D002118:Calcium
Schutzeffekt organischer Ca Antagonisten (Iproveratril, D 600, Prenylamin) gegenüber Isoproterenol-induzierten Myokardnekrosen.